Tag: statin

1. Patients who received statin therapy using a treat-to-target approach (targeting LDL-cholesterol of 50-70mg/dL) did not have worse cardiovascular outcomes ...

1. A randomized controlled trial found that pretreatment with supplemental vitamin D did not reduce the risk of statin-associated muscle ...

1. Olpasiran significantly and substantially reduced lipoprotein(a) concentration in patients with atherosclerotic cardiovascular disease compared to placebo. 2. Olpasiran reduced ...

1. 27.1% of patient in the statin group reported muscle pain and weakness compared to 26.6% in the control groups. ...

1. 3-year composite outcome of stroke and cardiovascular disease was comparable between both groups (9.1% combination vs. 9.9% monotherapy). 2. ...

1. This systematic review and meta-analysis found a modest absolute risk reduction of 0.8% in all-cause mortality from statin-induced therapy ...

1. A significantly greater proportion of patients receiving 2-3 lipid lowering medications achieved LDL-cholesterol targets compared to those receiving monotherapy. ...

1. Comparing statin and non statin using patients, there is no difference in rates of positive COVID-19 test result. 2. ...

1. A group of patients who newly initiated statins, compared to one that newly initiated another type of type 2 ...

1. Older patients with polypharmacy who discontinued statins had increased rates of admissions for heart failure, all-cause emergency hospital admissions, ...